Outpatient Clinic Note â€“ 2021-06-25
Interval history: Patient admits to missing tacrolimus doses due to work schedule. 
Exam: Stable vitals, no edema.
Labs: Tacrolimus trough 3.2 ng/mL (subtherapeutic). Creatinine 2.0 mg/dL.
DSA: Rebound anti-DQ7, MFI 5200.
Assessment: Subtherapeutic immunosuppression with recurrent DSA due to nonadherence.
Plan: Discussed risks, stressed importance of strict adherence, referred to pharmacy for adherence support.
